Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil enforces NAT (nucleic acid testing) for HCV (human immunodeficiency virus) and HIV

This article was originally published in Clinica

Executive Summary

Brazilian haematology centres are to use nucleic acid testing to screen all donated blood for the C-strain of the hepatitis virus (HCV) and the human immunodeficiency virus (HIV). The measure, enforced under a decree signed by health minister Jose Serra on February 5, was announced during the launch of a national hepatitis control programme. The use of nucleic acid testing is at the centre of the Brazilian health authorities' plans to improve the detection of hepatitis C and HIV/AIDS during the blood-screening process, and so reduce the high incidence of these diseases due to cross-infection through transfusion.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064776

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel